![{{press_release.company_name}} header image](https://res.cloudinary.com/dmgi9movl/image/upload/dpr_auto,w_auto/v1739814616/press_release/assets/header_images/Derek_Newell-CEO-PR_dgbn4c.jpg)
CuraLinc Healthcare (“CuraLinc” or the “Company”), a leading provider of workforce mental health and employee assistance (“EAP”) programs, is pleased to announce the appointment of Derek Newell as its new Chief Executive Officer. This planned transition began with Lightyear Capital’s (“Lightyear”) strategic investment in CuraLinc last year.
"We are thrilled to welcome Derek Newell as the new CEO of CuraLinc," said Michael Langer, Partner at Lightyear. “Derek's extensive experience and innovative approach to healthcare make him the ideal leader to guide CuraLinc through its next phase of growth.”
Derek brings over 25 years of experience in healthcare, with a strong background in employer benefits, behavioral health, wellness, consumer advocacy and health navigation, disease management, remote patient monitoring, virtual health and health information technology.
"I am honored to join CuraLinc and lead this exceptional organization," said Derek Newell, CEO of CuraLinc. “The Company has a strong foundation built on innovation, quality and a commitment to improving employee wellbeing. I am excited to work with the talented team at CuraLinc to continue delivering outstanding services and expanding our reach to support even more individuals and organizations."
With Derek now in place, Sean Fogarty will take an active role on CuraLinc’s Board of Directors as its Executive Chairman, supporting the organization’s growth and development. Sean founded CuraLinc in 2008 with a vision to revolutionize EAP and workforce mental health by focusing on three core pillars that remain in place today: access, quality and innovation. Under his leadership, CuraLinc has grown significantly, now supporting over 4,600 clients globally.
"I am incredibly proud of what we have achieved at CuraLinc over the last seventeen years and am excited for CuraLinc to continue to thrive and evolve under Derek’s guidance,” stated Sean Fogarty. “Derek's experience and vision will be instrumental in advancing our mission, and I look forward to supporting him in my new role at the Company and on the Board of Directors."
“We are confident that CuraLinc will continue to innovate and deliver exceptional value to its clients and partners with Derek as CEO,” added Michal Petrzela, Partner at Lightyear. “We also want to thank Sean for building a dynamic and mission-driven platform for workforce mental health that now supports the wellbeing of over ten million people around the world."
CuraLinc's commitment to providing transformative mental health care, fueled by connectivity and personalized advocacy, remains steadfast, with a core focus on supporting clients and caring for the millions who rely on its services.
About CuraLinc Healthcare
CuraLinc provides transformative mental health care fueled by connectivity – marrying technology and personalized advocacy to support employees, families and students through programs that have a measurable impact on their health, wellbeing and productivity. For more information, please visit curalinc.com.
About Lightyear Capital
Lightyear Capital is a New York-based private equity firm that partners with growing companies at the nexus of financial services and technology, health care and business services. For over 20 years, Lightyear has worked closely with management and leveraged its industry expertise, network of advisors and operating resources to accelerate growth and build market-leading businesses. As of September 30, 2024, the firm had assets under management of over $6.5 billion. For more information, please visit lycap.com.